
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is a prominent player in the tissue and hygiene sector, with over half of its sales derived from personal care products and a significant portion from consumer tissue products. The company's strategic focus on innovation is set to enhance its product offerings, supported by a robust pipeline planned for 2026, which is expected to leverage advanced technology and cater to evolving consumer needs. Additionally, Kimberly-Clark's diversified geographical sales, with just over half originating from North America and a growing presence in Europe, Asia, and Latin America, positions it for sustained growth and resilience in an increasingly competitive market.
Bears say
Kimberly-Clark is experiencing significant challenges, highlighted by a projected -4.0% decline in North American organic sales for the third quarter of 2025, in contrast to a previous estimate of +4.5%. The company also recorded a -2.7% decline in measured retail sales in the U.S. for the same period, indicating ongoing difficulties in maintaining market share. Additionally, forecasted earnings per share have been revised downward, with estimates reduced from $7.60 to $7.41 for fiscal 2025 and from $8.00 to $7.85 for 2026, reflecting a bearish outlook on the firm's financial performance.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares